Scope
Reference
C371747
Description
Vaccine mimic materials-comprising messenger RNA (mRNA) and lipid nanoparticles (LNPs)-from Helix-Biotech.
Contract 1. Helix Biotech Biosimilar mRNA Vaccines
Supplier
Contract value
- £150,000 excluding VAT
- £180,000 including VAT
Above the relevant threshold
Award decision date
10 November 2025
Standstill period
- End: 19 November 2025
- 8 working days
Earliest date the contract will be signed
24 November 2025
Contract dates (estimated)
- 1 December 2025 to 30 November 2027
- 2 years
Main procurement category
Goods
CPV classifications
- 33651600 - Vaccines
Procedure
Procedure type
Direct award
Supplier
Helix Biotech Inc.
- Public Procurement Organisation Number: PCMD-6995-GBGZ
1460 Breda Drive
Knoxville
37918
United States
Email: info@helix-biotech.com
Small or medium-sized enterprise (SME): No
Voluntary, community or social enterprise (VCSE): No
Supported employment provider: No
Public service mutual: No
Contract 1. Helix Biotech Biosimilar mRNA Vaccines
Contracting authority
Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency
- Public Procurement Organisation Number: PBMQ-7576-DVGW
10 South Colonnade
London
E14 4PU
United Kingdom
Region: UKI42 - Tower Hamlets
Organisation type: Public authority - central government